Skip to main content

Roche's Termination of Epigenomics Alliance Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 15.
 
1. Roche Abandons Biomarker-Development Alliance With Epigenomics (from Dec. 15)
 
2. White House to Consider NIH Bill That Would Reform Budget, Spending, Oversight, and Growth (Dec. 12)
 
3. Seeing Market Shift, Invitrogen to Exclusively Distribute Blue Heron's Synthetic Gene Products (Dec. 12)
 
4. New Company in London Will Help Forge Alliances Between Genomic Industry, Academia (Dec. 13)
 
5. IntegraGen Opens Subsidiary in US; Former Roche Exec Will Be CEO (Dec. 14)
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.